not approved
Low Molecular Weight Inhibitors (procyanidins and polyphenols) as sustainable nutraceutics for blood glucose regulation in diabetes mellitus and metabolic syndrome, powered by Cardano and Catalyst
Current Project Status
Unfunded
Amount
Received
Received
₳0
Amount
Requested
Requested
₳400,000
Percentage
Received
Received
0.00%
Solution
We will create natural food supplements based on extracts high in Low Molecular Weight Inhibitors (LMWI) to safely lower blood glucose levels in diabetes and metabolic syndrome patients.
Problem
Diabetes and metabolic syndrome are common diseases, together affecting more than 1,5 BILLION people worldwide (IDF, 2022) and drastically affecting their quality of life and well-being.
Feasibility
Value for money
Impact / Alignment
Team
Team Connections